Updated ICD-10-CM Coding Information from Genentech
October 03, 2025
Effective October 1, 2025, new ICD-10-CM codes will be available for use as released by the Centers for Medicare and Medicaid Services (CMS) regarding Rheumatoid Arthritis.
Affected Genentech product[s] and the corresponding new code[s] include:
Products | New Code |
Rituxan® (rituximab) for Immunology] ACTEMRA® (tocilizumab) | M05.A-Abnormal rheumatoid factor and anti-citrullinated protein antibody with rheumatoid arthritis |
A list of up-to-date sample coding by product is available for download/print directly from Genentech-Access.com and Genentech-Pro.com. Downloading the guide directly from the website ensures you have the most up-to-date information.
These codes are not all-inclusive; appropriate codes can vary by patient, setting of care and payer. Correct coding is the responsibility of the provider submitting the claim for the item or service. Please check with the payer to verify codes and special billing requirements. Genentech does not make any representation or guarantee concerning reimbursement or coverage for any item or service.
For questions or concerns, feel free to reach out to your local Genentech representative.